Abstract:OBJECTIVEHepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatic arterial chemoembolization transcatheter (TACE) is one of the main treatment methods for liver cancer. However, the long-term therapeutic effect of HCC after TACE is still unsatisfactory, postoperative recurrence and metastasis rate is still very high. Furthermore, TACE operation due to liver cancer tissue ischemia and hypoxia will lead to up-regulation of vascular endothelial growth factor (VEGF) expression. In the current study, we investigated the effects of suppressed VEGF on HCC and its molecular mechanism provided a basis for targeting angiogenesis.MATERIALS AND METHODSWe established rabbits primary HCC model by in situ embedding the VX2 subcutaneous transplantation tumor. Conventional Seldinger femoral artery and hepatic artery catheterization method were used to select the catheter over the tumor-bearing hepatic artery. The different groups were divided into TACE operation, and the experimental group was performed with the VEGF-siRNA molecular preparation in the catheter. 64-slice spiral CT were used to perfusion imaging of liver cancer model before and after TACE operation. We further assessed the efficiency of VEGF silencing and its influence on VX2 cells. The expression of VEGF mRNA and protein were detected by RT-PCR and Western blotting, respectively. Intratumoral microvessel density (MVD), VEGF and CD34 were evaluated by immunohistochemistry. We detected the cell apoptotic by immunofluorescence and flow cytometry.RESULTSOur findings indicated that VEGF-siRNA-2# could effectively suppress the expression of VEGF expression, inhibited the proliferation capability and promoted apoptosis of VX2 cells in vitro. Silencing of VEGF expression also suppress HCC tumor growth and reduce HCC angiogenesis in rabbits primary HCC model in vivo. Furthermore, We found that phosphoinositide 3-kinase (PI3K) and protein kinase B (AKT) activation were considerably reduced while inhibition VEGF expression in VX2 cells.CONCLUSIONSOur data demonstrated that VEGF silencing could suppress cells proliferation, promote cells apoptosis and reduce HCC angiogenesis through inactivation of VEGF/PI3K/AKT signaling pathway.

Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells Via Targeting RhoC in Vitro and in Vivo.

Role of RhoC-siRNA Expression Vector on Growth Velocity and Invasiveness of Hepatoma Carcinoma Cells

ROR-α-1 Inhibits the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma MHCC97H Via Downregulation of Chemokine CXCL5.

Construction of RhoC-siRNA expression vector and its role in invasion and metastasis ability of hepatoma carcinoma cell

Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Hepatic Stellate Cells Promote the Progression of Hepatocellular Carcinoma Through Microrna-1246-rorα-wnt/β-catenin Axis

Quercetin‐induced degradation of RhoC suppresses hepatocellular carcinoma invasion and metastasis

MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway

Down-regulation of CXCR7 Inhibits the Growth and Lung Metastasis of Human Hepatocellular Carcinoma Cells with Highly Metastatic Potential

Downregulation of CCR1 Inhibits Human Hepatocellular Carcinoma Cell Invasion

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway

Blockade of Rho/Rho-associated Coiled Coil-Forming Kinase Signaling Can Prevent Progression of Hepatocellular Carcinoma in Matrix Metalloproteinase-Dependent Manner.

The Rho GTPase Rnd1 Inhibits Epithelial–mesenchymal Transition in Hepatocellular Carcinoma and is a Favorable Anti-Metastasis Target

[Correlation of Expression of RhoC with Invasiveness of Prostate Cancer Cell Line PC-3M in Vitro].

C5aR Correlated with the Dissemination Capacity of Circulating Tumor Cells in Hepatocellular Carcinoma by Targeting INHBA-p-smad2/3-EMT/MMPs Axis.

RANKL Promotes Migration and Invasion of Hepatocellular Carcinoma Cells Via NF-κB-mediated Epithelial-Mesenchymal Transition.

RhoB Acts As a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma

MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway